These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37831700)

  • 1. Unique Pharmacokinetics for Oral Tacrolimus Administration After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia With Shwachman-Diamond Syndrome.
    Inoue Y; Uemura Y; Kosugi S; Kanno M; Sano F
    Am J Ther; 2024 May-Jun 01; 31(3):e318-e319. PubMed ID: 37831700
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene Polymorphism of Tacrolimus-Metabolizing Enzymes Associated With Impaired Absorption of Tacrolimus Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Matsuoka S; Tsutsumi Y; Kikuchi R; Ito S; Teshima T
    Transplant Proc; 2019 Apr; 51(3):998-1001. PubMed ID: 30979494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haploidentical stem cell transplantation for acute myeloid leukemia associated with adult-onset Shwachman-Diamond syndrome].
    Uemura Y; Hirakawa T; Matsunawa M; Kozuki K; Saiki Y; Takimoto M; Sano F; Watanabe K; Inoue Y; Arai A
    Rinsho Ketsueki; 2022; 63(2):94-98. PubMed ID: 35264508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
    Yano S; Mori S; Saito T; Yokoyama H; Machishima T; Shimada T; Yahagi Y; Sugiyama K; Ogasawara Y; Takahara S; Kasama K; Katsube A; Kamiyama Y; Suzuki K; Inui Y; Usui N; Aiba K; Yamashita T
    Ann Hematol; 2015 Mar; 94(3):491-6. PubMed ID: 25325985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R; Fujiwara S; Sasazaki M; Hirata Y; Yamamoto C; Uesawa M; Oh I; Matsuyama T; Mori M; Ozawa K; Muroi K
    Rinsho Ketsueki; 2012 Apr; 53(4):469-71. PubMed ID: 22687983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Umbilical Cord Blood Transplantation With Reduced-intensity Conditioning for Acute Myeloid Leukemia in a Child With Shwachman-Diamond Syndrome.
    Yoshimura S; Mizuno T; Osumi T; Shioda Y; Kiyotani C; Terashima K; Deguchi T; Nakadate H; Kato M; Matsumoto K; Tomizawa D
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e414-e418. PubMed ID: 32134838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation.
    Trifilio S; Rubin H; Monacelli A; Mehta J
    J Oncol Pharm Pract; 2021 Jun; 27(4):857-862. PubMed ID: 32659173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Int J Hematol; 2009 Jul; 90(1):103-107. PubMed ID: 19472033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.
    Nakamura Y; Matsuguma M; Tokunaga Y; Yamamoto K; Tanaka M; Tanaka Y; Yujiri T; Tanizawa Y
    Intern Med; 2017; 56(10):1199-1202. PubMed ID: 28502936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a report of three cases and literature review].
    Feng AH; Shi JM; Fu HR; Yu J; Zheng WY; Zhu YY; Huang H; Zhao YM
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):689-693. PubMed ID: 39231775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reaction to intravenous but not oral tacrolimus.
    Nicolai S; Bunyavanich S
    Transplantation; 2012 Nov; 94(9):e61-3. PubMed ID: 23128975
    [No Abstract]   [Full Text] [Related]  

  • 15. Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients.
    Yamazaki R; Mori T; Aisa Y; Kato J; Nakamura Y; Nakazato T; Mihara A; Ikeda Y; Okamoto S
    Transplant Proc; 2009 Jun; 41(5):1831-3. PubMed ID: 19545738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic hematopoietic stem cell transplantation for MDS secondary to Shwachman-Diamond syndrome: a case report].
    Zhou M; Jiang YW; Chen JJ; Wu C; Zou BB; Chen Z; Li L; Lei P; Liu GH; Tian YY; Zhu ML; Liu C
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):80. PubMed ID: 36987731
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
    Collins J; Shea K; Parsad S; Plach K; Lee P
    J Oncol Pharm Pract; 2020 Jan; 26(1):5-12. PubMed ID: 30854922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
    Nara M; Takahashi N; Miura M; Niioka T; Kagaya H; Fujishima N; Saitoh H; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1321-9. PubMed ID: 23354810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
    Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
    Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party.
    Cesaro S; Donadieu J; Cipolli M; Dalle JH; Styczynski J; Masetti R; Strahm B; Mauro M; Alseraihy A; Aljurf M; Dufour C; de la Tour RP
    Transplant Cell Ther; 2022 Oct; 28(10):637-649. PubMed ID: 35870777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.